Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance [Yahoo! Finance]
Codexis, Inc. (CDXS)
Last codexis, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.codexis.com/investors
Company Research
Source: Yahoo! Finance
US$70.39 million alongside a reduced net loss and new 2026 revenue guidance of US$72–76 million. The company also highlighted progress for its ECO Synthesis RNA manufacturing platform, including a new siRNA supply agreement for preclinical cardiovascular work and a major technology transfer deal with Merck that materially boosted results. With Codexis now posting quarterly profitability and outlining 2026 revenue expectations, we'll assess how this affects its enzyme-focused investment narrative. Outshine the giants: these 19 early-stage AI stocks could fund your retirement Codexis Investment Narrative Recap To own Codexis, you need to believe its ECO Synthesis platform can evolve from promising technology into a durable, revenue-generating engine, while the legacy pharma biocatalysis business remains a useful, if uneven, contributor. The key near term catalyst is clear evidence of repeat and scaling ECO Synthesis contracts, and the biggest risk is ongoing revenue lumpiness
Show less
Read more
Impact Snapshot
Event Time:
CDXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXS alerts
High impacting Codexis, Inc. news events
Weekly update
A roundup of the hottest topics
CDXS
News
- Codexis, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform [Seeking Alpha]Seeking Alpha
- Codexis (CDXS) was given a new $5.00 price target by Stifel Nicolaus.MarketBeat
- Codexis (CDXS) had its "overweight" rating reaffirmed by Cantor Fitzgerald.MarketBeat
- Codexis rises after Q4 beat, strong outlook [Seeking Alpha]Seeking Alpha
CDXS
Earnings
- 3/11/26 - Beat
CDXS
Analyst Actions
- 3/12/26 - Cantor Fitzgerald
CDXS
Sec Filings
- 3/11/26 - Form 10-K
- 3/11/26 - Form 8-K
- 3/11/26 - Form SCHEDULE
- CDXS's page on the SEC website